SCHEMBL16513811

SCHEMBL16513811

CN1CCN(c2ccc(Nc3ncc4cccc(-c5ccnc(C=CC(N)=O)c5)c4n3)cc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 5/20 0.60
JAK2 O60674 4/20 0.60
EGFR P00533 2/20 0.55
FGFR2 P21802 2/20 0.54
FGFR1 P11362 2/20 0.52
KDR P35968 1/20 0.52
SLC2A1 P11166 1/20 0.47
CDK4 P11802 5/20 0.47
CCND1 P24385 3/20 0.47
CCND2 P30279 2/20 0.47
CCND3 P30281 2/20 0.47
AURKA O14965 2/20 0.46
MAP4K1 Q92918 1/20 0.46
BTK Q06187 1/20 0.46
SYK P43405 1/20 0.46
FGFR4 P22455 2/20 0.45
CCNB2 O95067 1/20 0.45
CCNE2 O96020 1/20 0.45
CDK1 P06493 1/20 0.45
CCNB1 P14635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16514634 0.83 BRD4 (0.53) BRD4JAK2EGFRFGFR2FGFR1
SCHEMBL16513550 0.83 BRD4 (0.53) BRD4JAK2EGFRFGFR2FGFR1
SCHEMBL16514536 0.82 EGFR (0.70) BRD4JAK2EGFRFGFR2FGFR1
SCHEMBL16514597 0.81 TTK (0.56) BRD4JAK2EGFRFGFR2FGFR1
SCHEMBL29575830 0.81 JAK2 (0.66) BRD4JAK2EGFRFGFR2FGFR1
SCHEMBL19096959 0.80 MAPK10 (0.55) BRD4JAK2EGFRFGFR2CDK4
SCHEMBL16514362 0.80 JAK2 (0.70) BRD4JAK2EGFRFGFR2FGFR1
SCHEMBL29846917 0.80 JAK2 (0.70) BRD4JAK2EGFRFGFR2FGFR1
SCHEMBL29576100 0.80 JAK2 (0.67) BRD4JAK2EGFRFGFR2FGFR1
SCHEMBL16513961 0.80 BRD4 (0.73) BRD4JAK2EGFRFGFR2FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3035936-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NeuPharma, Inc. (US) 2016-06-29 EP disclosed
WO-2015027222-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC. (US) 2015-02-26 WO disclosed